Computational platform Way2Drug: from the prediction of biological activity to drug repurposing


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The Way2Drug informational-computational platform (www.way2drug.com/dr) provides access to the data on drugs approved for medicinal use in the USA and Russian Federation, as well as computational possibilities for the prediction of biological activity of drug-like organic compounds. Currently realized computational tools of the platform, which allow one to predict several thousands of biological activity types, including the interaction with molecular targets, pharmacotherapeutic and side effects, metabolism, acute toxicity for rats, cytotoxicity, influence on gene expression, and other properties characterizing the evaluation how promising are particular drug-like compounds as potential pharmaceuticals, are reviewed. Using the Way2Drug platform, one can not only select the most promising "hits" for the synthesis and testing of biological activity but also reveal new indications for the launched drugs.

作者简介

D. Druzhilovskiy

Institute of Biomedical Chemistry

编辑信件的主要联系方式.
Email: dmitry.druzhilovsky@ibmc.msk.ru
俄罗斯联邦, 10/8 Pogodinskaya ul., Moscow, 119121

A. Rudik

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
俄罗斯联邦, 10/8 Pogodinskaya ul., Moscow, 119121

D. Filimonov

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
俄罗斯联邦, 10/8 Pogodinskaya ul., Moscow, 119121

T. Gloriozova

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
俄罗斯联邦, 10/8 Pogodinskaya ul., Moscow, 119121

A. Lagunin

Institute of Biomedical Chemistry; N. I. Pirogov Russian National Research Medical University

Email: dmitry.druzhilovsky@ibmc.msk.ru
俄罗斯联邦, 10/8 Pogodinskaya ul., Moscow, 119121; 1 ul. Ostrovityanova, Moscow, 117997

A. Dmitriev

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
俄罗斯联邦, 10/8 Pogodinskaya ul., Moscow, 119121

P. Pogodin

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
俄罗斯联邦, 10/8 Pogodinskaya ul., Moscow, 119121

V. Dubovskaya

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
俄罗斯联邦, 10/8 Pogodinskaya ul., Moscow, 119121

S. Ivanov

Institute of Biomedical Chemistry; N. I. Pirogov Russian National Research Medical University

Email: dmitry.druzhilovsky@ibmc.msk.ru
俄罗斯联邦, 10/8 Pogodinskaya ul., Moscow, 119121; 1 ul. Ostrovityanova, Moscow, 117997

O. Tarasova

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
俄罗斯联邦, 10/8 Pogodinskaya ul., Moscow, 119121

V. Bezhentsev

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
俄罗斯联邦, 10/8 Pogodinskaya ul., Moscow, 119121

K. Murtazalieva

Institute of Biomedical Chemistry; N. I. Pirogov Russian National Research Medical University

Email: dmitry.druzhilovsky@ibmc.msk.ru
俄罗斯联邦, 10/8 Pogodinskaya ul., Moscow, 119121; 1 ul. Ostrovityanova, Moscow, 117997

M. Semin

Institute of Biomedical Chemistry; N. I. Pirogov Russian National Research Medical University

Email: dmitry.druzhilovsky@ibmc.msk.ru
俄罗斯联邦, 10/8 Pogodinskaya ul., Moscow, 119121; 1 ul. Ostrovityanova, Moscow, 117997

I. Maiorov

Institute of Biomedical Chemistry; N. I. Pirogov Russian National Research Medical University

Email: dmitry.druzhilovsky@ibmc.msk.ru
俄罗斯联邦, 10/8 Pogodinskaya ul., Moscow, 119121; 1 ul. Ostrovityanova, Moscow, 117997

A. Gaur

CSIR-Indian Institute of Chemical Technology

Email: dmitry.druzhilovsky@ibmc.msk.ru
印度, Hyderabad, 500 007

G. Sastry

CSIR-Indian Institute of Chemical Technology

Email: dmitry.druzhilovsky@ibmc.msk.ru
印度, Hyderabad, 500 007

V. Poroikov

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
俄罗斯联邦, 10/8 Pogodinskaya ul., Moscow, 119121

补充文件

附件文件
动作
1. JATS XML

版权所有 © Springer Science+Business Media, LLC, part of Springer Nature, 2017